COVID-19 Clinical Trial
Official title:
Online Support for Psychosocial Stress in the Context of the COVID-19 Pandemic
The COVID-19 pandemic leads to a greatly increased risk of substantial psychological stress worldwide. We intend to evaluate an online support program aiming at reducing stress in the context of the COVID-19 pandemic. The program consists of twelve modules that participants undergo, covering a broad range of topics related to stress in the context of the COVID-19 pandemic. It has been developed together with and is provided by Selfapy GmbH, Berlin. The aim of this randomised clinical trial with observational components is to estimate the effects of the intervention as a whole, as well as individual modules and selected chapters. Further, follow-up assessments as well as information on risks and the long-term course of COVID pandemic-related stress may help to elucidate COVID-19 pandemic stress across time and what we can do to prevent long-term negative consequences.
The overall aim of this randomised trial with observational component is to estimate the
effects of a guided digital online support program to increase mental health and reduce
psychosocial stress in the context of the COVID-19 pandemic. More specifically, the main
hypothesis is to estimate whether the improvement in mental health is stronger during the
first two weeks of applying the online support program as compared to a two weeks waiting
condition (with provision of WHO information on 'coping with stress during the 2019-nCoV'
outbreak only). In addition to the randomised control group (second arm: waiting condition,
followed by online support program), the study comprises as third arm a non-randomised
comparator condition, consisting of subjects not intending to participate in the online
support program. Furthermore, our aim is to estimate changes in the outcomes along taking
part in the program.
Additional research questions are:
- to compare the intervention effects across modules and chapters of the online support
program, including between module comparison with an unspecific, control (comparator)
module: "general information on the corona virus" and its unspecific chapters;
- to estimate the effects of selected modules on additional outcomes (e.g. physical
activity, and schooling related factors);
- to describe the magnitude and course of psychosocial stress, mental health and related
factors in the context of the COVID-19 pandemic;
- to estimate and predict which subjects profit most from specific parts of the program.
Follow-up assessment shall include estimating whether the program prevents the development of
detrimental mental health conditions, e.g. depression, anxiety, etc.
In order to make first study results available as early as possible, we intend to conduct
quick complete analyses (primary outcome and relevant parts of secondary/other outcomes):
These analyses will be conducted with data including subjects from the first 4 weeks of
recruitment, given that a sample size of at least 300 for the online support program arm and
a sample size of at least 300 for the waiting condition is reached; or if not yet reached
after 4 weeks of recruitment, as soon as a sample size of at least 300 for the online support
program arm and a sample size of at least 300 for the waiting condition is reached. However,
we intend to continue recruiting beyond this point in time and sample size (until the
COVID-19 pandemic situation has come to an end, i.e., vaccination is broadly available), to
allow further, also more detailed analyses at a later point in time, resulting in more
precise estimates.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT06065033 -
Exercise Interventions in Post-acute Sequelae of Covid-19
|
N/A | |
Completed |
NCT06267534 -
Mindfulness-based Mobile Applications Program
|
N/A | |
Completed |
NCT05047601 -
A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection
|
Phase 2/Phase 3 | |
Recruiting |
NCT04481633 -
Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection
|
N/A | |
Recruiting |
NCT05323760 -
Functional Capacity in Patients Post Mild COVID-19
|
N/A | |
Completed |
NCT04612972 -
Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru
|
Phase 3 | |
Completed |
NCT04537949 -
A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults
|
Phase 1/Phase 2 | |
Recruiting |
NCT05494424 -
Cognitive Rehabilitation in Post-COVID-19 Condition
|
N/A | |
Active, not recruiting |
NCT06039449 -
A Study to Investigate the Prevention of COVID-19 withVYD222 in Adults With Immune Compromise and in Participants Aged 12 Years or Older Who Are at Risk of Exposure to SARS-CoV-2
|
Phase 3 | |
Enrolling by invitation |
NCT05589376 -
You and Me Healthy
|
||
Completed |
NCT05158816 -
Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19
|
||
Recruiting |
NCT04341506 -
Non-contact ECG Sensor System for COVID19
|
||
Completed |
NCT04384445 -
Zofin (Organicell Flow) for Patients With COVID-19
|
Phase 1/Phase 2 | |
Completed |
NCT04512079 -
FREEDOM COVID-19 Anticoagulation Strategy
|
Phase 4 | |
Completed |
NCT05975060 -
A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants.
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT05542862 -
Booster Study of SpikoGen COVID-19 Vaccine
|
Phase 3 | |
Withdrawn |
NCT05621967 -
Phonation Therapy to Improve Symptoms and Lung Physiology in Patients Referred for Pulmonary Rehabilitation
|
N/A | |
Terminated |
NCT05487040 -
A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease
|
Phase 1 | |
Terminated |
NCT04498273 -
COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80
|
Phase 3 | |
Active, not recruiting |
NCT06033560 -
The Effect of Non-invasive Respiratory Support on Outcome and Its Risks in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)-Related Hypoxemic Respiratory Failure
|